Decision modelling of economic evaluation of intervention programme of breast cancer

, , , &
Journal of Evaluation in Clinical Practice 16 (6):1282-1288 (2010)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2009.01329.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,322

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Optimal two‐stage breast cancer screening for countries with intermediate or low incidence of breast cancer.Shou-Jen Kuo, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Dar-Ren Chen & Li-Sheng Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1345-1352.
Cost‐utility analysis of bevacizumab versus ranibizumab in neovascular age‐related macular degeneration using a Markov model.Jignesh J. Patel, Margaret As Mendes, Mark Bounthavong, Melissa Ld Christopher, Daniel Boggie & Anthony P. Morreale - 2012 - Journal of Evaluation in Clinical Practice 18 (2):247-255.
Cost‐effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.Meng-Kan Chen, Hui-Fang Hung, Stephen Duffy, Amy Ming-Fang Yen & Hsiu-Hsi Chen - 2011 - Journal of Evaluation in Clinical Practice 17 (6):1050-1058.
Breast cancer incidence: what do the figures mean?Ann Johnson & Jane Shekhdar - 2005 - Journal of Evaluation in Clinical Practice 11 (1):27-31.
Medical technology assessment and the role of economic evaluation in health care.E. M. M. Adang, A. Ament & C. D. Dirksen - 1996 - Journal of Evaluation in Clinical Practice 2 (4):287-294.
Model‐based cost‐effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation).Jonathan Karnon, Fiona Campbell & Carolyn Czoski-Murray - 2009 - Journal of Evaluation in Clinical Practice 15 (2):299-306.
Breast cancer screening in younger women: evidence and decision making.J. Mark Elwood - 1997 - Journal of Evaluation in Clinical Practice 3 (3):179-186.
Making Fair Funding Decisions for High Cost Cancer Care: The Case of Herceptin in New Zealand.E. Fenton - 2010 - Public Health Ethics 3 (2):137-146.
Decision analysis model evaluating the cost‐effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia.Mark Bounthavong & Mark P. Okamoto - 2007 - Journal of Evaluation in Clinical Practice 13 (3):453-460.
Exploring the requirements for a decision aid on familial breast cancer in the UK context: a qualitative study with patients referred to a cancer genetics service.Rachel Iredale, Frances Rapport, Stephanie Sivell, Wendy Jones, Adrian Edwards, Jonathon Gray & Glyn Elwyn - 2008 - Journal of Evaluation in Clinical Practice 14 (1):110-115.
Methodological limitations of cost‐effectiveness analysis in health care: implications for decision making and service provision.James Raftery - 1999 - Journal of Evaluation in Clinical Practice 5 (4):361-366.
Are More Alternatives Better for Decision-Makers? A Note on the Role of Decision Cost.Huei-Chung Lu, Mingshen Chen & Juin-Jen Chang - 2005 - Theory and Decision 58 (3):283-304.
Cost‐effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT).Gregory P. Samsa PhD, David B. Matchar Md, G. Rhys Williams ScD & David E. Levy Md - 2002 - Journal of Evaluation in Clinical Practice 8 (1):61-70.

Analytics

Added to PP
2013-11-24

Downloads
34 (#456,993)

6 months
8 (#352,434)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Stephen Duffy
University of Strathclyde
Tony Chen
University of British Columbia

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references